Private Advisor Group, LLC Halozyme Therapeutics, Inc. Transaction History

Private Advisor Group, LLC

$15.6 Billion
Q3 2024

A detailed history of Private Advisor Group, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 24,163 shares of HALO stock, worth $1.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,163

Previous 22,753 6.2%

Holding current value

$1.35 Million

Previous $1.19 Million 16.04%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$51.3 - $64.42 $72,333 - $90,832	1,410 Added 6.2%	24,163 $1.38 Million
Q2 2024 Aug 05, 2024	BUY	$37.81 - $52.4 $15,577 - $21,588	412 Added 1.84%	22,753 $1.19 Million
Q1 2024 Apr 30, 2024	SELL	$33.68 - $41.95 $37,384 - $46,564	-1,110 Reduced 4.73%	22,341 $908,000
Q4 2023 Feb 06, 2024	BUY	$33.32 - $42.1 $45,881 - $57,971	1,377 Added 6.24%	23,451 $866,000
Q3 2023 Nov 02, 2023	BUY	$36.46 - $44.03 $4,739 - $5,723	130 Added 0.59%	22,074 $843,000
Q2 2023 Aug 09, 2023	BUY	$30.28 - $38.74 $6,873 - $8,793	227 Added 1.05%	21,944 $791,000
Q4 2022 Jan 18, 2023	SELL	$40.06 - $59.44 $803,803 - $1.19 Million	-20,065 Reduced 48.02%	21,717 $0
Q3 2022 Oct 14, 2022	BUY	$38.53 - $51.78 $655 - $880	17 Added 0.04%	41,782 $1.65 Million
Q2 2022 Jul 13, 2022	SELL	$37.35 - $48.3 $261 - $338	-7 Reduced 0.02%	41,765 $1.84 Million
Q1 2022 May 12, 2022	SELL	$31.97 - $41.06 $1,214 - $1,560	-38 Reduced 0.09%	41,772 $1.67 Million
Q4 2021 Feb 10, 2022	SELL	$31.82 - $40.75 $1.32 Million - $1.69 Million	-41,424 Reduced 49.77%	41,810 $1.68 Million
Q3 2021 Oct 14, 2021	BUY	$38.47 - $46.42 $1.6 Million - $1.93 Million	41,534 Added 99.6%	83,234 $3.39 Million
Q1 2021 Apr 22, 2021	BUY	$39.51 - $51.45 $1.65 Million - $2.15 Million	41,700 New	41,700 $1.74 Million
Q4 2019 Feb 10, 2020	SELL	$14.93 - $19.53 $232,460 - $304,082	-15,570 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$15.2 - $17.69 $258 - $300	-17 Reduced 0.11%	15,570 $242,000
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $5,560 - $6,507	377 Added 2.48%	15,587 $268,000
Q1 2019 May 13, 2019	SELL	$13.94 - $17.58 $3,554 - $4,482	-255 Reduced 1.65%	15,210 $245,000
Q4 2018 Feb 11, 2019	BUY	$13.33 - $18.66 $206,148 - $288,576	15,465 New	15,465 $226,000

Others Institutions Holding HALO

# of Institutions

539

Shares Held

126M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.77B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.

Account

Private Advisor Group, LLC Halozyme Therapeutics, Inc. Transaction History